CHOUDHARY PATEL: Open Payments
NPI 1003843863 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 10 payments from 6 companies in 2025. Trend: 2023 $593 · 2024 $1,676 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $106 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Corium, LLC | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: SPRAVATO, INGREZZA, FANAPT, Azstarys, REXULTI, COBENFY.
Industry payments across CA — which companies pay providers there.
